Michael H Dosik, M.D. Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 22 Conscience Cir, Setauket, NY 11733 Phone: 631-751-5421 Fax: 631-751-7452 |
News Archive
Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced that patients treated with ISIS-CRPRx achieved rapid, dose-dependent mean reductions of up to 67 percent in C-reactive protein (CRP) in a Phase 2 study in patients with rheumatoid arthritis (RA).
Voting to boost funding for the National Institutes Health has long been a source of pride for Democrats and Republicans alike. But the drive to shrink the federal government is now eroding bipartisan backing for an agency that supports scientific research to prevent illnesses such as strokes, heart attacks and cancer.
Potentially life-threatening non-alcoholic fatty liver disease (NAFLD) in obese children has distinct characteristics, often different from those found in adults, according to a University of California, San Diego (UCSD) School of Medicine study led by Jeffrey Schwimmer, M.D., assistant professor of pediatrics.
Rainbow Coral Corp. positioned itself at the cutting edge of biotechnology innovation today by joining forces with BioHouston, Inc., one of the nation's preeminent drivers of life sciences research and commercialization.
› Verified 7 days ago